10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
21.65
-0.78 (-3.48%)
At close: May 4, 2026, 4:00 PM EDT
21.65
0.00 (0.00%)
Pre-market: May 5, 2026, 4:00 AM EDT

10x Genomics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,7932,0831,7566,6654,19816,640
Market Cap Growth
182.44%18.59%-73.65%58.77%-74.77%9.21%
Enterprise Value
2,3541,6331,4366,3603,85116,128
Last Close Price
21.6516.3114.3655.9636.44148.96
PE Ratio
--46.60-9.45-25.67-24.96-281.06
PS Ratio
4.343.242.8810.778.1333.93
PB Ratio
3.472.622.478.995.2120.35
P/TBV Ratio
3.402.562.448.855.1520.11
P/FCF Ratio
21.4616.01-306.53-104.46-25.40-135.67
P/OCF Ratio
20.5315.31263.52-438.55-124.91-778.55
EV/Sales Ratio
3.662.542.3510.287.4632.88
EV/EBITDA Ratio
--95.09-9.52-28.68-28.54-672.04
EV/EBIT Ratio
--26.77-7.38-23.97-22.93-308.66
EV/FCF Ratio
18.0912.55-250.66-99.69-23.30-131.50
Debt / Equity Ratio
0.090.090.100.110.110.09
Debt / EBITDA Ratio
-4.91-4.91-0.55-0.43-0.70-3.42
Debt / FCF Ratio
0.650.65-14.42-1.49-0.58-0.67
Net Debt / Equity Ratio
-0.55-0.55-0.44-0.40-0.42-0.62
Net Debt / EBITDA Ratio
25.5725.572.061.322.5021.11
Net Debt / FCF Ratio
-3.37-3.3754.254.602.044.13
Asset Turnover
0.660.660.650.620.500.50
Inventory Turnover
2.852.852.502.701.701.65
Quick Ratio
3.953.954.103.964.106.11
Current Ratio
4.464.464.974.694.856.77
Return on Equity (ROE)
-5.78%-5.78%-25.17%-32.98%-20.45%-7.48%
Return on Assets (ROA)
-6.79%-6.79%-21.23%-27.29%-16.81%-5.81%
Return on Invested Capital (ROIC)
-15.47%-15.47%-43.87%-56.91%-42.35%-21.95%
Return on Capital Employed (ROCE)
-7.22%-7.22%-23.74%-30.57%-18.59%-6.08%
Earnings Yield
-1.56%-2.15%-10.59%-3.90%-4.01%-0.36%
FCF Yield
4.66%6.25%-0.33%-0.96%-3.94%-0.74%
Buyback Yield / Dilution
-3.57%-3.57%-2.81%-2.90%-3.18%-9.09%
Total Shareholder Return
-3.57%-3.57%-2.81%-2.90%-3.18%-9.09%
Updated Feb 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q